Chargement en cours...

Activating Somatic FGFR2 Mutations in Breast Cancer

It is known that FGFR2 gene variations confer a risk for breast cancer. FGFR2 and FGF10, the main ligand of FGFR2, are both overexpressed in 5–10% of breast tumors. In our study, we sequenced the most important coding regions of FGFR2 in somatic tumor tissue of 140 sporadic breast cancer patients an...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Reintjes, Nadine, Li, Yun, Becker, Alexandra, Rohmann, Edyta, Schmutzler, Rita, Wollnik, Bernd
Format: Artigo
Langue:Inglês
Publié: Public Library of Science 2013
Sujets:
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC3603931/
https://ncbi.nlm.nih.gov/pubmed/23527311
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0060264
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!